Pure Global

"Carforson" involves a bone marrow section/tissue extraction needle - Taiwan Registration fb1f1b86ca51d14c52006548e26dcd09

Access comprehensive regulatory information for "Carforson" involves a bone marrow section/tissue extraction needle in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fb1f1b86ca51d14c52006548e26dcd09 and manufactured by BARD PERIPHERAL VASCULAR, INC.;; CAREFUSION 2200, INC.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
fb1f1b86ca51d14c52006548e26dcd09
Registration Details
Taiwan FDA Registration: fb1f1b86ca51d14c52006548e26dcd09
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Carforson" involves a bone marrow section/tissue extraction needle
TW: "ๅกๅผ—่ฟ…"ไป‹ๅ…ฅ้ซ”้ชจ้ซ“ๅˆ‡็‰‡๏ผ็ต„็น”ๆŠฝๅ–้‡
Risk Class 2

Registration Details

fb1f1b86ca51d14c52006548e26dcd09

DHA00601094501

Company Information

Product Details

For details, it is Chinese approved copy of the imitation order.

H Gastroenterology and urology

import

Dates and Status

Dec 06, 2004

Dec 06, 2024